73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

by Pohang University of Science & Technology (POSTECH)Credit: POSTECHAccording to Statistics Korea, cancer is the top cause of death in 2021, accounting for 26% of deaths. Most cancer patients mis

Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

by Pohang University of Science & Technology (POSTECH)Credit: POSTECHAccording to Statistics Korea, cancer is the top cause of death in 2021, accounting for 26% of deaths. Most cancer patients mis
Modest rise in UK cancer cases but substantial decline in deaths over last 25 years: Study

Modest rise in UK cancer cases but substantial decline in deaths over last 25 years: Study

by British Medical JournalCredit: Unsplash/CC0 Public DomainCases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also

Modest rise in UK cancer cases but substantial decline in deaths over last 25 years: Study

by British Medical JournalCredit: Unsplash/CC0 Public DomainCases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also
Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t
Study suggests a single dose of HPV vaccine provides years of protection from cancer

Study suggests a single dose of HPV vaccine provides years of protection from cancer

by Rita Reyburn and Professor Fiona Russell,University of MelbourneCredit: AI-generated imageAt some point in their life, it's estimated that around 80% of people will be infected with the h

Study suggests a single dose of HPV vaccine provides years of protection from cancer

by Rita Reyburn and Professor Fiona Russell,University of MelbourneCredit: AI-generated imageAt some point in their life, it's estimated that around 80% of people will be infected with the h
Study reports progress in long-term protection against ovarian cancer tumors

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or
Cancer research explores role of cytochrome oxygenases in augmenting austocystin D-mediated cytotoxicity

Cancer research explores role of cytochrome oxygenases in augmenting austocystin D-mediated cytotoxicity

byTokyo University of SciencePrevious studies have suggested that austocystin D is oxidized by cytochrome P450 (CYP) oxygenases which then induces DNA damage and suppresses cell proliferation. I

Cancer research explores role of cytochrome oxygenases in augmenting austocystin D-mediated cytotoxicity

byTokyo University of SciencePrevious studies have suggested that austocystin D is oxidized by cytochrome P450 (CYP) oxygenases which then induces DNA damage and suppresses cell proliferation. I
New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Molecular subtypes of advanced kidney cancer matter for treatment response

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the
Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

byHelmholtz Association of German Research CentresMPS layout; red—media circuit with integrated pump; blue—pneumatic connectors; yellow—microwells for organoids; green—LUER-connectors). Credit:&

Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

byHelmholtz Association of German Research CentresMPS layout; red—media circuit with integrated pump; blue—pneumatic connectors; yellow—microwells for organoids; green—LUER-connectors). Credit:&
Researchers uncover on/off switch for breast cancer metastasis

Researchers uncover on/off switch for breast cancer metastasis

by Rebecca McClellan,Stanford UniversitySongnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases. High protein levels le

Researchers uncover on/off switch for breast cancer metastasis

by Rebecca McClellan,Stanford UniversitySongnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases. High protein levels le
Research suggests metabolite differences in young-onset versus average-onset colorectal cancer

Research suggests metabolite differences in young-onset versus average-onset colorectal cancer

byCleveland ClinicCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0New research from Cleveland Clinic supports the theory that environmental exposures—such as red

Research suggests metabolite differences in young-onset versus average-onset colorectal cancer

byCleveland ClinicCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0New research from Cleveland Clinic supports the theory that environmental exposures—such as red